Organizing committee invites all participants from all over the world to attend “14th International Conference on Genetic Disorders and Gene Therapy’’ during November 25-26, 2020 London, UK.

Genetic is a global overview with the Theme: “Pasture for an Imminent Technologies in Genetics” is designed for professionals at all levels and career phases of the Genetics, Gene therapy  and Genomics, who want to improve their understanding of what will drive and shape the future of the market. This will include senior executives, sales and marketing personnel, strategic planners, who will be benefit from a broad overview of the Genetics, Gene therapy and Genomics. The strength of the Conference is that the participants tend to include all phases of the value chain as well as individuals from a wide variety of sector and countries.

Why to attend???

Genetics 2020  may be a world stage for exhibiting analysis regarding designation, hindrance and management and exchanging concepts regarding it and through this fashion, adds to the unfold of data in Genetic Disorders and Gene Therapy for the advantage of every learned community and business. The organizing committee of the Genetics 2020 is preparing for associate energizing and instructive meeting program furthermore as comprehensive lectures, symposia, workshops on an expansion of topics, poster displays and various programs for participants from all over the world. It will also prove to be a brilliant open door for the representatives from Universities and Institutes to cooperate with the world class researchers and an outstanding opportunity for businesses keen at expanding their global market reach. We tend to ask you to the Genetics2020, where you will confirm to possess a major experience with students from all around the world. All members of the commercial Genetics 2020, organizing committee expect to fulfill you in London, UK.

Target Audience:

• Scientists
• Young  research  fellows
• Research Scholars
• Residents, Fellows & Post Docs
• Students
• Agro, Bio, Chemical, Medical, Pharma, Technology Companies
• Business Executives & Directors
• Genetics Industries
• Gene therapy research labs
• Genetics researchers
• Genetics entrepreneurs
• Health care industries
• Venture capital, private equity, and institutional investors
• Training institutes
• Advertising Agency Executives
• Genomics associations
• Industry professionals

Market Growth of Genetics:

Genetic Testing Market size was valued at USD 10.6 billion in 2017 and is expected to witness more than 11.6% CAGR from 2018 to 2024. Increasing demand from patients for personalized medicines will fuel the demand for genetic testing during the forthcoming years. Personalized medicine offers tailored medical treatment to patients based on their molecular basis. Various developed economies such as Europe undergo genetic testing for detection of various genetic and rare diseases. Detection of genetic diseases at an early stage facilitates early treatment and helps reduce severity of diseases. Growing adoption of personalized medicines coupled with increasing awareness regarding early diagnosis of disease will boost the industry growth over the forecast period.

According to a study published by NCBI, about 75,000 genetic tests are available on the market as of August 217. These include nearly 10,000 separate exams. In addition, there have been more than 14,000 trials on the market since March 2014. With about 10 new tests increasing every day for more than four years, the market for genetic testing has gained momentum.

Technological advancement in genetic testing is expected to drive the genetic testing market during the coming years. The demand for genetic testing is increasing across the globe owing to the availability of new tests as well as advancement in the genetic testing techniques. Innovations in tests that offer safer and efficient techniques of disease detection, surpassing the risk of miscarriage during early stages of pregnancy will serve to be a high impact rendering factor that will drive the genetic testing market growth during the forthcoming years. Dearth of experienced professionals and advanced infrastructure in developing as well as under developed economies is should hamper the market growth over the forecast period. Accessibility to quality healthcare in low resource areas is difficult to maintain owing to lack of infrastructure. Moreover, risk of false interpretations associated with unavailability of experienced professionals will restrain industry growth noticeably.

Best Regards,
Irene Hazel | Program Director        
Genetics 2020           
Phone: +448000148923
WhatsApp No: +44 7480728209
Email: genetics@brainstormingmeetings.com
Website: www.genetics.insightconferences.com/